Showing 1631-1640 of 5853 results for "".
Moving Toward a More Tolerable Treatment for AK
https://practicaldermatology.com/topics/general-topics/moving-toward-a-more-tolerable-treatment-for-ak/20760/A conversation with Peter Friedman, MD, PhD about non-thermal, atmospheric pressure plasma.Time to Revamp Your Practice Website
https://practicaldermatology.com/topics/practice-management/time-to-revamp-your-practice-website/18706/Your website is your digital storefront. To optimize the benefit of your site, you must review it frequently to be sure you are making the most of technological advancements and search rankings. Keep an eye toward an outstanding user experience (UX). Learn what you need to know to keep your websiteGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoThoughts on Superpotent Topical Corticosteroids in Children
https://practicaldermatology.com/topics/psoriasis/thoughts-on-superpotent-topical-corticosteroids-in-children/18684/"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but super potent topical corticosteroids can be used safely and effectively for pediatric psoriasis patients, he says. Jerry Bagel, MD agrees, in this bonus video from the Clinical ConveTaltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goinCutaneous Oncology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/cutaneous-oncology/18638/Maui Derm Course Director George Martin, MD, recaps the discussion from the Cutaneous Oncology session during Maui Derm 2016. He shares his protocol for short-contact PDT therapy with an abbreviated incubation for reducing pain during treatment. Dr. Martin also offers an important clinical pearl forAnonymous Reviews on Google+ and How They Impact Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/anonymous-reviews-on-google-and-how-they-impact-your-dermatology-practice/18827/Online reviews are a fact of modern medical practice. Many physicians fret over negative reviews, but what about positive reviews? Learn how reviews influence your search rankings, how patients assess reviews, and how you can create a Google+ page that allows for anonymous reviews of your practice.Gold Mettle: Dr. Michael Gold Talks Multifaceted Practice with Dr. Joel Cohen
https://practicaldermatology.com/topics/practice-management/gold-mettle-dr-michael-gold-talks-multifacted-practice-with-dr-joel-cohen/18868/Dr. Michael Gold's thriving Nashville practice includes a busy medical practice, a medical spa, and a research center. Plus, he's involved in teaching and educational ventures globally. How does he do it all—and stay on schedule? Dr. Joel L. Cohen finds out.Understanding the SGR: An Explainer
https://practicaldermatology.com/topics/practice-management/understanding-the-sgr-an-explainer/21194/How did the SGR come to be? If it goes away, what will happen to the misplaced focus on physician payments?Off-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.